The clinical value of human leukocyte antigen HLA-DRB1 subtypes associated to Graves’ disease in Romanian population

By Martin Sorina   Dutescu Monica Irina   Sirbu Anca   Barbu Carmen   Albu Alice   Florea Suzana   Fica Simona  

Immunological Investigations, Vol. 43, Iss. 5, 2014-07 ,pp. : 479-490

Informa Healthcare

Access to resources Recommend Favorite

Synchronous Decline of Serum-Soluble HLA Class I Antigen and beta-Cell Function in Insulin-Dependent Diabetes Mellitus

By Nakanishi K.   Kobayashi T.   Komatsu Y.   Kogawa N.   Hagihara M.   Tsuji K.  

Clinical Immunology, Vol. 85, Iss. 3, 1997-12 ,pp. : 246-252

Academic Press

Access to resources Recommend Favorite

Downregulation of expression of transporters associated with antigen processing 1 and 2 and human leukocyte antigen I and its effect on immunity in nasopharyngeal carcinoma patients

By                          

Molecular and Clinical Oncology, Vol. 2, Iss. 1, 2014-01 ,pp. : 51-58

Spandidos Publications

Access to resources Recommend Favorite

Acid treatment of lymphocytes selectively decreases the expression of HLA class I antigens: a method to confirm that a positive clinical crossmatch test was due to class I antibodies

By Sumitran-Karuppan S.   Moller E.  

Transplant Immunology, Vol. 4, Iss. 2, 1996-06 ,pp. : 163-168

Elsevier

Access to resources Recommend Favorite

The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones

By Vitale M.  

International Immunology, Vol. 11, Iss. 1, 1999-01 ,pp. : 29-35

Oxford University Press

Access to resources Recommend Favorite